Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2011

View Archived Issues

Supernus Pharma reports on phase IIa trial of SPN-812 in adults with ADHD

ChronTech initiates phase IIb trial of its HCV DNA vaccine with Inovio's MedPulser delivery device

First oral LH receptor agonist induces ovulation in healthy women

Phase I trial of E-3810 under way in patients with advanced cancer

AZ-13 and AZ-78 reduce beta-amyloid production in vitro and in vivo

Array BioPharma and Genentech prepare new B-raf inhibitors

Georgetown University investigators design novel apoptosis inducers

Marina Biotech begins phase Ib/IIa trial of oral CEQ-508 in familial adenomatous polyposis

Simcere files IND in China for APX-003

New radiolabeled polypeptide bioconjugates presented as agents to image apoptosis

New tetrahydroisoquinoline derivatives for cancer patented by University of Tennessee

Omthera Pharma raises funds for phase III Epanova trial

Transcept Pharma begins phase II TO-2061 trial in obsessive-compulsive disorder

Biothera begins phase I/II trial of Imprime PGG in chronic lymphocytic leukemia

Phase II trial of PD-0332991 advances in patients with KRAS-mutant colorectal cancer

Lantheus Medical Imaging and FDA agree on SPA for phase III flurpiridaz F 18 trial

Impax discloses topline data from phase III ADVANCE-PD trial of IPX-066

Teysuno approved in E.U. for advanced gastric cancer

Repligen's phase III study of RG-1068 in pancreatic imaging meets coprimary endpoints

Cerenis begins phase II CHI-SQUARE trial of CER-001 in patients with ACS

Interim phase I data support safety and promising activity of namitecan in solid tumors

Meiji Seika and RaQualia enter into license agreement for ziprasidone in Japan

FDA approves Bayer's contrast agent Gadavist for MRI of the CNS

Pivotal COMFORT-II study of Incyte's ruxolitinib meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...